Clinical trials
Advanced or Metastatic Non-small Cell Lung Cancer clinical trials
Below are recruiting advanced or metastatic non-small cell lung cancer clinical trials, each written for real people, not researchers. We’re tracking 5,673 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06693817Recruiting
Wireless sensors for newborns in the delivery room
This trial tests advanced wireless sensors to monitor babies born at 35 weeks or later who are stable at delivery. The goal is to see if these sensors can improve care right after birth.
Londrina, ParanáAges 8 months–10 months - NCT06702800Recruiting
Using tumor models to predict breast cancer drug response
This study uses a personal lab-grown model of your tumor (called an organoid) to help predict which drugs are most likely to work for your specific breast cancer. It is open to both early-stage and advanced breast cancer patients who are about to start or are already receiving treatment.
Changsha, HunanAges 18–70 - NCT07276529Recruiting
Magnet procedure safety trial for colon surgery patients
This trial tests a new magnet device to connect sections of the colon after surgery. It may be an option for people who need part of their colon removed and are otherwise in good health.
Orlando, FloridaAges 22 years+ - NCT07688278Recruiting
Diabetes screening for people with advanced gum disease
This trial tests whether checking blood sugar (HbA1c) at the dentist can find undiagnosed diabetes. It is for adults with advanced periodontitis (severe gum disease) who have not already been told they have diabetes.
SkåneAges 18 years+ - NCT02332668RecruitingPhase 1/Phase 2
Pembrolizumab for children with advanced, hard-to-treat cancer
This trial tests pembrolizumab (an immunotherapy that helps the body recognize and attack cancer) in children with advanced solid tumors or lymphoma that can’t be cured. It’s designed for kids who have already tried standard treatments or don’t have standard treatment options.
Aurora, ColoradoAges 6 months–17 years - NCT07107230RecruitingPhase 1
Study of JNJ-95437446 for advanced solid tumors
This trial tests a new drug, JNJ-95437446, in people with certain advanced cancers (non-small cell lung, colorectal, or head and neck cancer). The goal is to see if it can help shrink or control the cancer.
Sarasota, FloridaAges 18 years+ - NCT07560982Recruiting
Improving medication adherence in advanced heart failure
This study looks at whether patients with severe heart failure follow their prescribed medications as recommended by treatment guidelines. The researchers want to understand what helps or prevents patients from taking their medicines correctly, which could improve their heart function and symptoms.
BergamoAges 18–75 - NCT07552714Recruiting
Thread Embedding and Ear Acupressure for Sleep Problems
This study tests whether special threads placed under the skin combined with acupressure on the ears can help people with chronic insomnia (long-term sleep trouble). The treatment is based on Traditional Chinese Medicine ideas about balancing energy in the body.
Ho Chi Minh City, CityAges 40–75 - NCT07403604RecruitingPhase 1
Lowering Insulin to Reduce Fat Buildup in the Liver
This study tests if lowering insulin levels can reduce fat buildup in the liver for people with a fatty liver condition called MASLD. It's looking for adults who are overweight and have early signs of insulin resistance but not diabetes.
New York, New YorkAges 18–65 - NCT07037966Recruiting
Portable brain MRI for multiple sclerosis
This study tests a new portable brain MRI to see if it can help diagnose multiple sclerosis. It may be easier to use than regular machines.
ValenciaAges 18–65 - NCT06712511Recruiting
Coffee's effect on energy and caffeine breakdown
This study looks at how coffee affects your body's energy use and how quickly you process caffeine. It may help explain why coffee affects people differently.
Shenzhen, GuangdongAges 18–40 - NCT06712667Recruiting
Coffee and intense exercise: a caffeine metabolism study
This study looks at how coffee affects people who do intense exercise, and how their bodies process caffeine. It may help understand if coffee can improve exercise performance or recovery.
Shenzhen, GuangdongAges 18–40 - NCT06713252Recruiting
Art therapy for stroke recovery
This study tests whether art therapy can help improve non-motor symptoms (like mood and thinking) during the early recovery phase after a stroke. Participants will attend art sessions while continuing their regular rehab.
Jiamusi, HeilongjiangAges 40–75 - NCT06714929Recruiting
School water study for students in grades K-5
This study looks at how a new water program in schools might affect student health and hydration. It includes watching what kids drink at lunch, checking teeth and body weight for older students, and asking 4th and 5th graders and staff about their drinks.
Henrico, VirginiaAges 4 years+ - NCT06722846Recruiting
Helping patients with advanced cancer plan care
This study looks at ways to help people with advanced cancer or aggressive lymphoma make better treatment decisions with their doctors. If you qualify, you'll be asked to read a short story about a patient in a similar situation and answer questions about your thoughts on care options.
Houston, TexasAges 18 years+ - NCT06728410RecruitingPhase 2
Pemigatinib plus durvalumab for advanced bile duct cancer
This trial tests a combination of two drugs, pemigatinib and durvalumab, in people with a certain type of advanced bile duct cancer that has a specific genetic change (FGFR2 fusion or rearrangement). The goal is to see if this combination can help when standard treatments have stopped working.
Birmingham, AlabamaAges 18 years+ - NCT06730555Recruiting
HIV and hepatitis C testing for people who inject drugs
This study works with syringe service programs to see if offering opt-out HIV and hepatitis C testing helps more people get screened and connected to care. It focuses on programs that do not already offer this testing and are in high-need areas.
Miami, FloridaAges 18 years+ - NCT06731361Recruiting
Better prescribing for older nursing home residents
This study tests a better way for doctors to prescribe medicines for older nursing home residents. The goal is to make sure prescriptions are safer and more tailored to each person.
Apeldoorn, GelderlandAges 65 years+ - NCT06731452Recruiting
Brain health study with MRI and TMS
This study looks at brain activity patterns in healthy adults. You'll have an MRI and a non-invasive brain stimulation session (TMS) to help researchers understand how the brain works. If you're already in The BrainHealth Project, this is a chance to learn more about your own brain health.
Dallas, TexasAges 22–100 - NCT06732505RecruitingPhase 1
Ac-225 DOTATATE for SSTR+ GEP-NETs: A Safety Study
This trial tests a new drug, Ac-225 DOTATATE, in people with a type of gut or pancreas tumor (GEP-NET) that has specific proteins (SSTR) on its surface. The goal is to see if it is safe and helps shrink or slow the tumor.
Beijing, Beijing MunicipalityAges 18–80 - NCT06740487Recruiting
AR therapy for PTSD in military members
This study tests a new therapy using augmented reality (a type of headset that adds digital images to what you see) to help treat posttraumatic stress disorder (PTSD) in current or former military members. The therapy aims to make exposure therapy more effective by letting you face trauma-related situations in a controlled, virtual way.
Charleston, South CarolinaAges 18 years+ - NCT06744790Recruiting
Predicting breathing trouble after surgery with a new sensor
This trial tests a new sensor that monitors your breathing to predict if you might have trouble after surgery. It is for people who are staying overnight in the hospital and getting extra oxygen through a face mask.
Baltimore, MarylandAges 18 years+ - NCT06746194Recruiting
PET scan to check treatment response in advanced liver cancer
This trial uses a special PET scan (68Ga-FAPI) to see how well systemic therapy is working in people with advanced liver cancer that can't be removed by surgery. The goal is to find a better way to measure treatment effectiveness.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06760819RecruitingPhase 2
Sevacertinib for solid tumors with HER2 mutations
This study tests an oral tablet called sevacertinib in people with solid tumors (not lung cancer) that have a HER2 mutation. It aims to see how well the drug works and how safe it is for people who have tried other treatments or have no good options left.
Birmingham, AlabamaAges 18 years+
Hear when a new Advanced or Metastatic Non-small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for advanced or metastatic non-small cell lung cancer?
- Yes. Clin2 currently lists 5,673 recruiting advanced or metastatic non-small cell lung cancer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a advanced or metastatic non-small cell lung cancer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a advanced or metastatic non-small cell lung cancer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
- Locally Advanced or Metastatic Non-small Cell Lung Cancer
- Metastatic Non-squamous Non Small Cell Lung Cancer
- Advanced Non-squamous Non-small-cell Lung Cancer
- NSCLC (Advanced Non-small Cell Lung Cancer)
- Non Small Cell Lung Cancer Metastatic
- Non Small Cell Lung Cancer
- Non-squamous Non-small Cell Lung Cancer
- Locally Advanced Non-Small Cell Lung Cancer
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.